Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The genetics of Charcot-Marie-Tooth disease: current trends and future implications for diagnosis and management.
[Pathology of the Peripheral Nervous System in Guillain-Barré Syndrome].
Monitoring multiple sclerosis by multimodal evoked potentials: Numerically versus ordinally scaled scoring systems.
Multiple sclerosis.
Experimental Neuromyelitis Optica Induces a Type I Interferon Signature in the Spinal Cord.
Regulation of Th1 cells and experimental autoimmune encephalomyelitis by glycogen synthase kinase-3.
The epidemiology of neuromyelitis optica amongst adults in the Merseyside county of United Kingdom.
Systematic review of pharmacologic therapies for neuropathic pain associated with stroke, HIV, trauma, and multiple sclerosis.
Exogenous Adult Post Mortem Neural Precursors attenuate secondary degeneration, and promote myelin sparing and functional recovery following experimental spinal cord injury.
Aquaporin-4: A novel diagnostic biomarker for seronegative neuromyelitis optica.
An update on the use of natalizumab in the treatment of multiple sclerosis: appropriate patient selection and special considerations.
Impact of Helicobacter pylori on multiple sclerosis-related clinically isolated syndrome.
Exacerbation of experimental autoimmune encephalomyelitis in mice deficient for DCIR, an inhibitory C-type lectin receptor.
[Infection risks in multiple sclerosis therapy by infusion of disease modifying drugs].
Heterogeneity of root and nerve ultrasound pattern in CIDP patients.
Improvement of driving skills in persons with Relapsing-Remitting Multiple Sclerosis: a pilot study.
A systematic analysis of the complement pathways in patients with neuromyelitis optica indicates alteration but no activation during remission.
[Targeted Therapy and Progressive Multifocal Leukoencephalopathy (PML): PML in the Era of Monoclonal Antibody Therapies].
An electrophysiological classification associated with Guillain-Barré syndrome outcomes.
Feasibility and reproducibility of whole brain myelin water mapping in 4 minutes using fast acquisition with spiral trajectory and adiabatic T2prep (FAST-T2) at 3T.
[Animal model of neuromyelitis optica].
Functional polarization of neuroglia: Implications in neuroinflammation and neurological disorders.
Neuroimmunotherapies Targeting T Cells: From Pathophysiology to Therapeutic Applications.
The ideal healthcare: priorities of people with chronic conditions and their carers.
Maturation and electrophysiological properties of human pluripotent stem cell-derived oligodendrocytes.
Pages
« first
‹ previous
…
653
654
655
656
657
658
659
660
661
…
next ›
last »